Thomas A Mace

6PUBLICATIONS
41CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 27, 2026
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia.

Ayushi Das, Debasmita Mukherjee, Liliana D'Alesio

|May 23, 2024
Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma.

Valentina Pita-Grisanti, Ericka Velez-Bonet, Kaylin Chasser

|Nov 03, 2023
Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors.

Yizhen Guo, Bryan C Remaily, Justin Thomas

|Sep 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.

Alyssa Marie M Castillo, Trang T Vu, Sophia G Liva

|Jun 26, 2020
CD200 promotes immunosuppression in the pancreatic tumor microenvironment.

Fouad Choueiry, Molly Torok, Reena Shakya

|Jul 25, 2019
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.

Ashley Pinette, Elizabeth McMichael, Nicholas B Courtney

Pageof 1

Frequent Collaborators

4 joint publications

Christopher C Coss

3 joint publications

Justin Thomas

3 joint publications

Mitch A Phelps

2 joint publications

Dwight H Owen